Cartesian Therapeutics In... (RNAC)
NASDAQ: RNAC
· Real-Time Price · USD
9.42
-0.23 (-2.38%)
At close: Oct 16, 2025, 3:59 PM
9.60
1.91%
After-hours: Oct 16, 2025, 05:55 PM EDT
-2.38% (1D)
| Bid | 9.32 |
| Market Cap | 244.94M |
| Revenue (ttm) | 1.03M |
| Net Income (ttm) | -36.26M |
| EPS (ttm) | -0.68 |
| PE Ratio (ttm) | -13.85 |
| Forward PE | -2.65 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 10.75 |
| Volume | 90,772 |
| Avg. Volume (20D) | 64,000 |
| Open | 9.66 |
| Previous Close | 9.65 |
| Day's Range | 9.33 - 10.05 |
| 52-Week Range | 8.46 - 26.50 |
| Beta | 0.38 |
| Ex-Dividend Date | n/a |
About RNAC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RNAC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RNAC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCartesian Therapeutics Inc. is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+21.86%
Cartesian Therapeutics shares are trading higher a...
Unlock content with
Pro Subscription
